Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine
- PMID: 2823089
Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine
Abstract
[3H]beta-funaltrexamine ([3H]beta-FNA) bound irreversibly to bovine striatal membranes. Naloxone inhibited the irreversible binding of 5 nM [3H]beta-FNA in a dose-dependent manner and maximally inhibited this binding at approximately 1 microM. Thus, the specific irreversible binding of [3H]beta-FNA to opioid receptors was defined as that which could be inhibited by 1 microM naloxone. This specific irreversible binding of [3H]beta-FNA was characterized. Exclusion of Na+ from the incubation medium reduced the specific binding of [3H]beta-FNA, and Na+ could be substituted by Li+ but not by K+, Cs+, Mg2+, or guanylylimidodiphosphate. The specific irreversible binding was saturable, time- and temperature-dependent, and was linearly related to tissue mass. Several drugs were used to characterize this specific binding. Levorphanol was 1000 times more potent as an inhibitor than dextrorphan. mu Opioid ligands (sufentanil and morphine) were much better inhibitors than delta (ICI174,864) or kappa (U50,488H) ligands. The potency of [D-Ala2, D-Leu5]enkephalin (DADLE) was between those of sufentanil and ICI174,864. These results demonstrated that under appropriate conditions [3H]beta-FNA specifically and irreversibly bound to the mu opioid binding site. Membrane preparations labeled with [3H]beta-FNA in the presence or absence of 1 microM naloxone or beta-FNA were subjected to polyacrylamide gel electrophoresis under denaturing and reducing conditions. Fluorograms showed that [3H]beta-FNA specifically bound to a protein (most likely the mu opioid binding site) that migrated as a band with a molecular weight range of 68,000-97,000. Such electrophoretic behavior indicates that it is likely to be a glycoprotein. The glycoprotein nature was confirmed by its adsorption onto a wheat germ lectin-Sepharose column after solubilization and subsequent elution by N-acetyl-D-glucosamine. In this lectin column eluate, the mu opioid receptor was the only protein band labeled by [3H]beta-FNA in the total binding preparation, and no labeled protein was observed in the nonspecific binding preparation. When the wheat germ lectin column eluate of the total binding was treated with peptide:N-glycosidase F, the broad labeled band of Mr 68,000-97,000 became a sharp band of Mr 57,000 with high radioactivity and a faintly labeled band of Mr 49,000.
Similar articles
-
Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.Mol Pharmacol. 1993 Oct;44(4):749-56. Mol Pharmacol. 1993. PMID: 8232225
-
Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.Mol Pharmacol. 1990 Feb;37(2):243-50. Mol Pharmacol. 1990. PMID: 2154672
-
Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.Synapse. 1991 Jun;8(2):86-99. doi: 10.1002/syn.890080203. Synapse. 1991. PMID: 1652797
-
Irreversible ligands as probes for drug receptors.NIDA Res Monogr. 1991;112:256-83. NIDA Res Monogr. 1991. PMID: 1661379 Review.
-
Problems and approaches in studying membrane opioid receptors.NIDA Res Monogr. 1991;111:69-84. NIDA Res Monogr. 1991. PMID: 1663582 Review.
Cited by
-
Mu opioids and their receptors: evolution of a concept.Pharmacol Rev. 2013 Sep 27;65(4):1257-317. doi: 10.1124/pr.112.007138. Print 2013. Pharmacol Rev. 2013. PMID: 24076545 Free PMC article. Review.
-
Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.Neurochem Res. 1996 Nov;21(11):1363-8. doi: 10.1007/BF02532377. Neurochem Res. 1996. PMID: 8947926
-
Effects of defeat stress on behavioral flexibility in males and females: modulation by the mu-opioid receptor.Eur J Neurosci. 2015 Feb;41(4):434-41. doi: 10.1111/ejn.12824. Epub 2015 Jan 23. Eur J Neurosci. 2015. PMID: 25615538 Free PMC article.
-
Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox.Pharmacol Res Perspect. 2021 Dec;9(6):e00887. doi: 10.1002/prp2.887. Pharmacol Res Perspect. 2021. PMID: 34713624 Free PMC article.
-
Detection of the endogenous mu opioid receptor (mopr) in brain.Front Biosci (Elite Ed). 2009 Jun 1;1(1):220-7. doi: 10.2741/E21. Front Biosci (Elite Ed). 2009. PMID: 19482639 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Research Materials